PACE at the National Patient Advocate Foundation Policy Consort

To accelerate the research that leads to new cancer treatments, we need policies that support continuous innovation. Hear more from Eli Lilly and Company CEO John C. Lechleiter, Ph.D., at “Scoring Progress Against Cancer: A New Tool to Track Continuous Innovation, and Public Policies to Speed It Up.”